EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

THE GENDER-AGE FEATURES OF PREVALENCE OF THE RISK FACTORS IN THE PATIENTS WITH SHARP CORONARY SYNDROME/ACUTE MYOCARDIAL INFARCTION BY THE DATA OF THE REGISTER IN ONE OF THE REGION OF TASHKENT.

Urinov O.*, Mamutov R. SH., Abidova D. E. and Mamrajapova D.A.

ABSTRACT

In Uzbekistan there has been noted the growth of morbidity and mortality because of cardio-vascular diseases (CVD) over the last two decades and the structure of the common mortality does not differ from the world: cardio-vascular diseases are also the most important cause of the death[1,2,3]. The increase of morbidity and referrals to the doctors (the quantity of the registered patients) due to CVD ( from 1410,0 to 2228,7 and from 7200,5 to 7541,5) заболеваемости and morbidity (i.e. quantity(amount) of the registered patients) from ССЗ (according to 1410,0 up to 2228,7 and with 7200,5 up to 7541,5, respectively) in 2004 -2009 indicates about activation of the identification and taking into account of the patients with cardio-vascular pathology[4]. The development of ACS/AMI is accompanied by high frequency of cases of hospital death and not fatal cardiovascular complications, the leading role in which development is allocated to the risk factors (RF) not only to separate, but also to their associations, especially, that potentiates an opportunity of the development of disease and its outcome in dependence on the number of RF. It is important also, that the potential of each RF may have regional differences. The concept of risk factors (RF), based on the results of started in 1948 Framingham heart study is a scientific basis of prevention of the cardiovascular diseases (CVD)[5,6,7]. In this research has been revealed that the main risk factors of CVD of atherosclerotic genesis are presented by arterial hypertension (AH), hypercholesteremia (HCS), smoking, obesity, diabetes mellitus (DM) and low level of physical activity, and also high level of triglycerides in the blood and low level of cholesterol of high density lipoproteins, age and gender. These main risk factors of CVD, forming the total risk and influencing on the prognosis, may be determined at the relatively simple screening observation with use of standard methods of examinations[8]. In the numerous epidemiological studies there has been proved that performance in time of preventive measures in the relation of RFs can reduce morbidity and mortality due to CVD[9,10]. Purpose. To study the gender-age features of the prevalence of risk factors (RF) in the patients with ACS/AMI on the basis of the register in one of the regions of Tashkent. Material and methods. The data from cohort prospective study “Register of acute myocardial infarction and acute coronary syndrome in one of the regions of Tashkent” were the basis for present study. ACS and AMY were studied among the constant population in one of the regions of Tashkent with analysis of the following documentation: the date of the “03” service, medical histories and extracts from case reports, ambulatory cards from the polyclinic histories of illnesses and extracts from стационара, out-patient maps from polyclinic, protocols of openings, certificates from the service of forensic medicine, certificates of death from the municipal registration system. There were used populational-preventive, statistic, mathematic methods with calculation of the criteria χ2 and Mac-Nimar for determination of the reliable differences of the qualitative parameters. Results. The risk factors of ACS/AMI were found in 683 (100%) of patients, including 1 RF – in 40(5,8%) patients, 2RF – in 129(18,9%), 3RF – in 21831,9%), 4RF – in 147(21,5%), >5 – in 149 (22,0%). Arterial hypertension was on the first place – 81,7%, increased BMI – on the second place -81,2%, smoking – on the third – 44,5%, hypercholesteremia (HCS) – on the fourth -37,5%, DM – on the fifths place -32,5%.

Keywords: .


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 April 2021 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR: APRIL ISSUE PUBLISHED

    APRIL Issue has been successfully launched on 1 April 2021.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )